Apellis Pharmaceuticals sees stock surge on strong drug revenues, but AI may offer more upside
ago 2 mois
HEALTH
Apellis Pharmaceuticals sees stock surge on strong drug revenues, but AI may offer more upside
2 cross-referenced sources
Learn more about this topic
Keywords
#
healthcare stocks
#
biopharmaceutical
#
EMPAVELI
#
product revenues
#
AI stocks
+2
You might also like
TECHNOLOGY
POET Technologies Forges Partnerships to Advance AI Optical Interconnects
ago 2 mois
TECHNOLOGY
Rackspace Technology Launches UK Sovereign Cyber Recovery Cloud with Rubrik
ago 2 mois
TECHNOLOGY
Unity Software Raises Revenue Outlook Driven by Strong Vector Business Performance
ago 2 mois
TECHNOLOGY
AI Startup Backed by NVIDIA Seeks Billions in Funding
ago 2 mois
TECHNOLOGY
Pharma Giant Eli Lilly Partners with AI Firm for New Medicines
ago 2 mois